Advanced search
Publication Cover
Autoimmunity Volume 35, 2002 - Issue 1
Submit an article Journal homepage
30
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Soluble Fas Ligand-susceptible "Memory" Cells in Mice but Not in Human: Potential Role of Soluble Fas Ligand in Deletion of Auto-reactive Cells

Sunshin Kim Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
,
Ja Young Kim Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
,
Tae H. Lee Department of Biology, Yonsei University College of Science, Seoul, South Korea
,
Kyungho Suk Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
,
Hoon-Suk Cha Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
,
Eun-Mi Koh Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
,
Hideo Yagita Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan
&
Myung-Shik Lee Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
 show all
Pages 15-20 | Published online: 07 Jul 2009

  • Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., et al., (1996) "Fas ligand in human serum", Nat. Med. 2, 317 - 322
  • Schneider, P., Holler, N., Bodmer, J.-L., Hahne, M., Frei, K., Fontana, A., et al., (1998) "Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity", J. Exp. Med. 187, 1205 - 1213
  • Tanaka, M., Suda, T., Takahashi, T. and Nagata, S. (1995) "Expression of the functional soluble form of human Fas ligand in activated lymphocytes", EMBO J. 14, 1129 - 1135
  • Owen-Schaub, L.B., Yonehara, S., Crump, W.L. and Grimm, E.A. (1992) "DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement", Cell. Immunol. 140, 197 - 205
  • Miyawaki, T., Uehara, T., Nibu, R., Tsuji, T., Yachie, A., Yonehara, S., et al., (1992) "Differential expression of apoptosis-related Fas antigen on lymphocytes subpopulations in human peripheral blood", J. Immunol. 149, 3753 - 3758
  • Nishimura, Y., Ishii, A., Kobayashi, Y., Yamasaki, Y. and Yonehara, S. (1995) "Expression and function of mouse Fas antigen on immature and mature T cells", J. Immunol. 154, 4395 - 4403
  • Suda, T., Tanaka, M., Miwa, K. and Nagata, S. (1996) "Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand", J. Immunol. 157, 3918 - 3924
  • Kim, Y.-H., Kim, S., Kim, K.-A., Yagita, H., Kayagaki, N., Kim, K.-W., et al., (1999) "Apoptosis of pancreatic b-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes", Eur. J. Immunol. 29, 455 - 465
  • Kim, S., Kim, K.-A., Hwang, D.-Y., Lee, T.H., Kayagaki, N., Yagita, H., et al., (2000) "Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved", J. Immunol. 164, 2931 - 2936
  • Shimada, A., Rohane, C., Fathman, C.G. and Charlton, B. (1996) "Pathogenic and protective role of CD45Rblow CD4+ cells collrelate with cytokine profiles in the spontaneously autoimmune diabetic mouse", Diabetes 45, 71 - 78
  • Tanaka, M., Itai, T., Adachi, M. and Nagata, S. (1998) "Downregulation of Fas ligand by shedding", Nat. Med. 4, 31 - 36
  • Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, N.F., et al., (1982) "The 1982 revised criteria for the classification of systemic lupus erythematosus", Arthritis Rheum. 25, 1271 - 1277
  • Stalder, T., Hahn, S. and Erb, P. (1994) "Fas antigen is the major target molecule for CD4+T cell-mediated cytotoxicity", J. Immunol. 152, 1127 - 1133
  • Powrie, F., Correa-Oliveira, R., Mauze, S. and Coffman, R.L. (1994) "Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity", J. Exp. Med. 179, 589 - 600
  • Holmes, K. and Fowlkes, B.J. (1991) "Flow cytometry", In: Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. and Strober, W., eds, Current Protocols in Immunology (Greene Publishing Associates and Wiley-Interscience, New York), p 5.3.9
  • Michie, C.A., McLean, A., Alcock, C. and Beverley, P.C. (1992) "Lifespan of human lymphocytes subsets defined by CD45 isoforms", Nature 360, 264 - 265
  • Bell, E.B., Sparshott, S.M. and Bunce, C. (1998) "CD4+T-cell memory, CD45R subsets and the persistence of antigen-a unifying concept", Immunol. Today 19, 60 - 64
  • Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. and Nagata, S. (1992) "Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediate apoptosis", Nature 356, 314 - 317
  • Horiuchi, T., Nishizaka, H., Yasunaga, S., Higuchi, M., Tsukamoto, H., Hayashi, K., et al., (1999) "Association of Fas/APO-1 gene polymorphism with systemic lupus erythematosus in Japanese", Rheumatology 38, 516 - 520
  • Emlen, W., Niebur, J. and Kadera, R. (1994) "Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus", J. Immunol. 152, 3685 - 3691
  • Cheng, J., Zhou, T., Liu, C., Shapiro, J.P., Brauer, M.J., Keifer, M.C., et al., (1994) "Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule", Science 263, 1759 - 1762
  • Nozawa, K., Kayagaki, N., Tokano, Y., Yagita, H., Okumura, K. and Hasimoto, H. (1997) "Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases", Arthritis Rheum. 40, 1126 - 1129
  • Jodo, S., Kobayashi, S., Kayagaki, N., Ogura, N., Feng, Y., Amasaki, Y., et al., (1997) "Serum level of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases", Clin. Exp. Immunol. 107, 89 - 95
  • Seino, K., Iwabuchi, K., Kayagaki, N., Miyata, R., Nagaoka, I., Matsuzawa, A., et al., (1998) "Chemotactic activity of soluble Fas ligand against phagocytes", J. Immunol. 161, 4484 - 4488

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.